Helus Pharma Inc. Common Stock
HELP
65 hedge funds and large institutions have $19.5M invested in Helus Pharma Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 12 closing their positions.
133% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 12
113% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 8
30% more funds holding
Funds holding: 50 → 65 (+15)
4.27% less ownership
Funds ownership: 13.88% → 9.62% (-4.3%)
62% less capital invested
Capital invested by funds: $51.9M → $19.5M (-$32.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.41M |
| 2 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$819K |
| 3 |
CCG
Ceeto Capital Group
Coral Gables,
Florida
|
+$170K |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$125K |
| 5 |
CAC
Cowen and Company
New York
|
+$100K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$8.29M |
| 2 |
O
OrbiMed
New York
|
-$4.87M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.65M |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
-$876K |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$549K |
HELP Hedge Fund Activity: Q4 2021 in Review
65 of the 6,520 institutional investors tracked by Wall St. Rank reported a position in Helus Pharma Inc. Common Stock (HELP) for Q4 2021, worth a combined $19.5M — down 62% from $51.9M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new HELP positions and 12 closed out — a net gain of 16 holders — while 17 added to existing stakes and 8 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $1.41M. The largest seller was Citadel Advisors, cutting an estimated $8.29M.
- 65 institutional investors held Helus Pharma Inc. Common Stock (HELP) as of Q4 2021, up from 50 in Q3 2021.
- Funds reported $19.5M of Helus Pharma Inc. Common Stock stock for Q4 2021, down 62% quarter-over-quarter.
- 28 funds opened new Helus Pharma Inc. Common Stock positions in Q4 2021 and 12 closed out, a net change of +16 holders.
- The largest Helus Pharma Inc. Common Stock buyer in Q4 2021 was BlackRock, an estimated $1.41M added.
- The largest Helus Pharma Inc. Common Stock seller in Q4 2021 was Citadel Advisors, an estimated $8.29M sold.
Based on aggregated 13F filings for Q4 2021.